Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Arena Pharmaceuticals, Inc.
(NQ:
ARNA
)
8.060
USD
+0.140 (+1.77%)
Official Closing Price
/ Updated:
4:00 PM EDT, May 23, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Arena Pharmaceuticals, Inc.
< Previous
1
2
...
64
65
66
67
68
69
70
71
Next >
Arena Pharmaceuticals (ARNA) Prices 12.5M Shares at $4.17
July 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4781545 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
July 08, 2009
from
PR Newswire
Arena Pharmaceuticals (ARNA) To File Mixed Securities Shelf
July 07, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4780178 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals Announces Public Offering of Common Stock
July 07, 2009
from
PR Newswire
WallStSense.com Fundamental & Technical Coverage of ARNA, UCBH, OSCI, MVSN, CELG and AINV
July 02, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by WallStSense.com
Read More
from
Marketwired News Releases
Rodman & Renshaw Initiates Coverage of Arena Pharmaceuticals (ARNA) with a Market Outperform
June 24, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4751679 for the full story.
Read More
from
StreetInsider.com News Articles
InvestorSoup.com Researches Wall Street Movers: Antigenics, Arena Pharma, Liz Claiborne, Powerwave Tech, Avis Budget Group, Unisys
June 18, 2009
from
PR Newswire
Arena Pharmaceuticals to Present at the Piper Jaffray Fourth Annual Europe Conference
June 18, 2009
from
PR Newswire
Arena Pharma (ARNA) Agrees to Receive $100M from Deerfield Management
June 17, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4737066 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals to Receive $100 Million from Deerfield Management
June 17, 2009
from
PR Newswire
Arena Pharmaceuticals (ARNA) NewsBite - One of Today's Top Gainers
June 15, 2009
Arena Pharmaceuticals (ARNA) leads the list of top gainers so far today and is now at $5.33, up $0.34 (6.81%) on volume of 2,743,341 shares traded. Over the last 52 ...(Click the story link or go to...
Read More
category
ARNA
from
MarketIntelligenceCenter.com
AnalystChoice.com Brings You the Best Complimentary Research Report on PLCM, SEPR, ARNA and CTIC
June 15, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by AnalystChoice.com (AC).
Read More
from
Marketwired News Releases
FDA Calendar Updates: MITI, KERX, GSK, DYAX, ARNA, PGNX (ARNA, rated BUY)
June 08, 2009
Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of about 200 entries. The calendar was originally created by Mike Havrilla to track...
Read More
category
Healthcare
,
Biotechnology & Drugs
from
SocialPicks.com: Front Page Picks
Positive Trial Results For Arena Pharmaceuticals
June 08, 2009
Arena Pharmaceuticals Inc. (Nasdaq: ARNA) reported positive results from a late stage clinical trial of its obesity treatment lorcaserin sending the stock price soaring $1.00 to close at $4.94....
Read More
from
MarketMinute.com Stock News
Arena Pharmaceuticals Inc (ARNA) is a BUY
June 08, 2009
ARNA - Break Out http://www.chartspread.com/stockcharts.php/?ticker=arna Arena Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in discovering, developing, and commercializing...
Read More
category
Healthcare
,
Biotechnology & Drugs
from
SocialPicks.com: Front Page Picks
Flat Close For Markets
June 08, 2009
Despite a promise by President Obama to create 600,000 jobs, the markets closed flat with the Dow adding a point to 8764 as commodities prices retreated. Nasdaq lost 7 points to 1842.
Read More
category
Market News
from
MarketMinute.com Market Updates
Unusual 11 Mid-Day Movers 6/8: ANPI, MFRI, RSOL, KERX Higher; XTNT, EMIS, AGEN, AIB Lower
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4715013 for the full story.
Read More
from
StreetInsider.com News Articles
Morning Movers 6/8: ANPI, MITI, KERX, DYAX, MSPD, MNKD Higher; AIB, LYG, XTNT, IRE Lower
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4714145 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals (ARNA) Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss
June 08, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4713416 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals Announces Lorcaserin Data Demonstrating Highly Significant Categorical and Absolute Weight Loss and Improvements in Secondary Endpoints Associated with Cardiovascular Risk
June 06, 2009
from
PR Newswire
Arena Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference
June 05, 2009
from
PR Newswire
Arena Pharmaceuticals Announces the Presentation of Lorcaserin Phase 3 BLOOM Data at the American Diabetes Association's 69th Scientific Sessions
June 01, 2009
from
PR Newswire
MaybachFinancial.com Posts Free Analyst Report on SUSQ, CVBF, ARNA and PAAS
May 22, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Maybach
Read More
from
Marketwired News Releases
Barclays Gets Bullish On US Biotechnology Sector (BBH)
May 20, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4671142 for the full story.
Read More
from
StreetInsider.com News Articles
10 Extreme Trades on Pending Clinical Trial Results (ARNA, rated SELL)
May 13, 2009
10 Extreme Trades on Pending Clinical Trial Results <font> http://biomedreports.com/articles/most-popular/979-10-extreme... </font> As a follow-up to my recent <font> article on nine extreme FDA...
Read More
category
Healthcare
,
Biotechnology & Drugs
from
SocialPicks.com: Front Page Picks
Arena Pharmaceuticals to Present at the 34th Annual Deutsche Bank Health Care Conference
May 13, 2009
from
PR Newswire
Arena Pharmaceuticals (ARNA) Miss Q1 Revenue View
May 11, 2009
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=4638126 for the full story.
Read More
from
StreetInsider.com News Articles
Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
May 11, 2009
from
PR Newswire
Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
May 05, 2009
from
PR Newswire
TheFortuneFinancial.com Initializes Free Analyst Research on ACOR, ARNA, SCHN and STLD
April 27, 2009
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by TheFortuneFinancial.com.
Read More
from
Marketwired News Releases
< Previous
1
2
...
64
65
66
67
68
69
70
71
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here